Results 11 to 20 of about 2,377,300 (402)

Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines

open access: yesEuropean Journal of Health Economics, 2020
Background Several multi-attribute utility instruments (MAUIs) are available from which utilities can be derived for use in cost-utility analysis (CUA).
Matthew Kennedy-Martin   +7 more
semanticscholar   +1 more source

QALY league table of Iran: a practical method for better resource allocation

open access: yesCost Effectiveness and Resource Allocation, 2021
Background The limited health care resources cannot meet all the demands of the society. Thus, decision makers have to choose feasible interventions and reject the others. We aimed to collect and summarize the results of all cost utility analysis studies
Reza Hashempour   +4 more
doaj   +1 more source

Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke

open access: yesInternational Journal of Stroke, 2020
Background Recently, two randomized controlled trials demonstrated the benefit of mechanical thrombectomy performed between 6 and 24 h in acute ischemic stroke.
E. Pizzo, M. Dumba, K. Lobotesis
semanticscholar   +1 more source

Cost-effectiveness of seven-days-per-week rehabilitation schedule for acute stroke patients

open access: yesCost Effectiveness and Resource Allocation, 2023
Background Rehabilitation is an essential medical service for patients who have suffered acute stroke. Although the effectiveness of 7-days-per-week rehabilitation schedule has been studied in comparison with 5- or 6-days-per-week rehabilitation schedule,
Yasuhiro Morii   +7 more
doaj   +1 more source

Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. [PDF]

open access: yes, 2015
BACKGROUND: Recent pertussis outbreaks have prompted re-examination of post-exposure prophylaxis (PEP) strategies, when immunization is not immediately protective.
Crowcroft, Natasha S   +3 more
core   +7 more sources

Health Economics of Antibiotics

open access: yesPharmaceuticals, 2010
Antibiotics have made a significant contribution to improving patient health, but policy makers and health care payers are concerned about the costs of antibiotics in addition to their effectiveness.
Steven Simoens
doaj   +1 more source

Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial. [PDF]

open access: yes, 2011
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
A Brooks   +68 more
core   +3 more sources

The death of cost-minimization analysis? [PDF]

open access: yes, 2001
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Altman   +21 more
core   +2 more sources

Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy

open access: yesClinicoEconomics and Outcomes Research, 2021
Gianni Ghetti,1 Maria Claudia D’Avella,2 Lorenzo Pradelli1 1Department of Health Economics and Outcome Research, AdRes, Turin, Italy; 2Department of Market Access, Sanofi, Milan, ItalyCorrespondence: Gianni GhettiDepartment of Health Economics and ...
Ghetti G, D'Avella MC, Pradelli L
doaj  

Cost-utility analysis of thrombolytic therapy [PDF]

open access: yesEuropean Heart Journal, 1991
An analysis of the cost-effectiveness of thrombolytic therapy was performed, based on 3- to 5-year follow-up data, from 533 patients randomized to receive conventional therapy or intracoronary streptokinase. At the 3-year follow-up, mortality was 22% in the former group and 14% after thrombolysis.
Jeroen Vos   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy